Grant: CIHR Fellowship
McGill University
$127,500.00
Characterising the cellular role of C9ORF72 in health and ALS/FTLD Pathology
EF 2014-15
Résumé
Amyotrophic lateral sclerosis (ALS for short) is a devastating neurological disorder caused by the degeneration of motor neurons in the spinal cord. These cells are critical to life as they carry signals from the brain to our muscles to tell them to contract. Without sufficient healthy motor neurons, patients develop a progressive paralysis that eventually leads to their death, often though respiratory failure. Frontotemporal lobar degeneration (FTLD) is a related disease process involving damage to the temporal and/or frontal lobes of the brain. It results in a progressive decline in behavior and/or language and in increased difficulty in planning or organizing activities, behaving appropriately in social/work settings and caring for oneself. It therefore leads to increased dependency on caregivers. Both ALS and FTLD commonly show onset in the 5th decade of life and sadly lack effective therapies. It has been discovered that many cases of ALS and FTLD are caused by alterations in specific genes, that is, ALS and FTLD can be inherited. Recently, mutation of a gene called C9ORF72 was shown to be the most common genetic cause of ALS as well as FTLD with as many as 40% of inherited ALS cases and 21% of FTLD cases involving a C9ORF72 mutation. This high frequency of C9ORF72 mutations represents a unique chance to develop a therapeutic approach for these debilitating disorders. However, the function of the C9ORF72 protein is unknown. The experiments outlined in this proposal will provide new insight into the function of the C9ORF72 protein and therefore pave the way for new therapeutic discoveries for ALS and FTLD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318694
Name
Kaneb Hannah M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Characterising the cellular role of C9ORF72 in health and ALS/FTLD Pathology
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$127,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Amyotrophic Lateral Sclerosis; C9orf72; Crispr/Cas9; Denn Domain Proteins; Direct Conversion Of Patient Fibroblasts To Neurons; Frontotemporal Lobar Degeneration; Guanine-Nucleotide Exchange Factor Activity; Membrane Trafficking; Patient Fibroblasts; Rab Proteins
Abstract
Amyotrophic lateral sclerosis (ALS for short) is a devastating neurological disorder caused by the degeneration of motor neurons in the spinal cord. These cells are critical to life as they carry signals from the brain to our muscles to tell them to contract. Without sufficient healthy motor neurons, patients develop a progressive paralysis that eventually leads to their death, often though respiratory failure. Frontotemporal lobar degeneration (FTLD) is a related disease process involving damage to the temporal and/or frontal lobes of the brain. It results in a progressive decline in behavior and/or language and in increased difficulty in planning or organizing activities, behaving appropriately in social/work settings and caring for oneself. It therefore leads to increased dependency on caregivers. Both ALS and FTLD commonly show onset in the 5th decade of life and sadly lack effective therapies. It has been discovered that many cases of ALS and FTLD are caused by alterations in specific genes, that is, ALS and FTLD can be inherited. Recently, mutation of a gene called C9ORF72 was shown to be the most common genetic cause of ALS as well as FTLD with as many as 40% of inherited ALS cases and 21% of FTLD cases involving a C9ORF72 mutation. This high frequency of C9ORF72 mutations represents a unique chance to develop a therapeutic approach for these debilitating disorders. However, the function of the C9ORF72 protein is unknown. The experiments outlined in this proposal will provide new insight into the function of the C9ORF72 protein and therefore pave the way for new therapeutic discoveries for ALS and FTLD.
Competitiondate
201411
Approvedterm2
2 yrs 10 mths
Pinamesdelim
Kaneb, Hannah M
Approvedterm
2 ans 10 mois
Cihrcontribution2
~ $127,500~ $0~